Biosimilar User Fee Talks Begin With Industry Negotiating Amongst Itself
FDA asks negotiators from the four industry groups to coordinate proposed changes as BsUFA renewal talks get underway.
FDA asks negotiators from the four industry groups to coordinate proposed changes as BsUFA renewal talks get underway.